No Data
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Cuts Target Price to $220
Teleflex Is Maintained at Hold by Truist Securities
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $200
RBC Cuts Price Target on Teleflex to $220 From $245, Keeps Outperform Rating
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Mizuho Securities Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $230